Frequencies of CD33+CD11b+HLA-DRCD14CD66b+ and CD33+CD11b+HLA-DRCD14+CD66b Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19
Front.med.
; 7: 1-2, 2020.
Article
em Pt
| LILACS, CONASS, ColecionaSUS, SES-SP, SESSP-IALPROD, SES-SP
| ID: biblio-1416578
Biblioteca responsável:
BR91.2
Localização: BR91.2
ABSTRACT
Common clinical features of patients with Coronavirus disease-2019 (COVID-19) vary from fever, to acute severe respiratory distress syndrome. Several laboratory parameters are reported as indicators of COVID-19 severity. We hereby describe the possible novel severity biomarkers for COVID-19, CD11b+CD33+HLA-DR-CD14+ cells and CD11b+CD33+HLA-DR-CD66b+ cells.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
CONASS
/
LILACS
/
SES-SP
/
SESSP-IALPROD
/
ColecionaSUS
Assunto principal:
Sangue
/
Antígenos HLA-DR
/
Coronavirus
/
Febre
Idioma:
Pt
Revista:
Front.med.
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Brasil